Li Ai

Infigratinib (BGJ398) in previously treated patients with advanced or metastatic cholangiocarcinoma with FGFR2 fusions or rearrangements: mature results from a multicentre, open-label, single-arm, phase 2 study

Milind Javle, Sameek Roychowdhury, Robin Kate Kelley et al. · ˜The œLancet. Gastroenterology & hepatology · 2021 · 425 citations

Medicine, Oncology, Cancer Pharmacology +13

Novel dopamine-modified oxidized sodium alginate hydrogels promote angiogenesis and accelerate healing of chronic diabetic wounds

Jinhua Chi, Li Ai, Mingyu Zou et al. · International Journal of Biological Macromolecules · 2022 · 104 citations

Engineering, Bioengineering, Biomedical Engineering +14

Umbilical Cord Mesenchymal Stem Cell Transfusion Ameliorated Hyperglycemia in Patients with Type 2 Diabetes Mellitus

Dexiao Kong, Xianghua Zhuang, Daoqing Wang et al. · Clinical Laboratory · 2014 · 86 citations

Medicine, Endocrinology, Immunology +17

Differential regulation of mRNAs and lncRNAs related to lipid metabolism in two pig breeds

Wanlong Huang, Xiuxiu Zhang, Li Ai et al. · Oncotarget · 2017 · 50 citations · Full text

Life Sciences, Animal Sciences, Molecular Biology +17

Primary overall survival (OS) from OPTiM, a randomized phase III trial of talimogene laherparepvec (T-VEC) versus subcutaneous (SC) granulocyte-macrophage colony-stimulating factor (GM-CSF) for the treatment (tx) of unresected stage IIIB/C and IV melanoma.

Howard L. Kaufman, Robert Hans Ingemar Andtbacka, Frances A. Collichio et al. · Journal of Clinical Oncology · 2014 · 44 citations

Medicine, Clinical Sciences, Oncology +16